94 related articles for article (PubMed ID: 18309089)
1. Lysophosphatidic acid induces rapid and sustained decreases in epidermal growth factor receptor binding via different signaling pathways in BEAS-2B airway epithelial cells.
Kassel KM; Dodmane PR; Schulte NA; Toews ML
J Pharmacol Exp Ther; 2008 Jun; 325(3):809-17. PubMed ID: 18309089
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid decreases epidermal growth factor receptor binding in airway epithelial cells.
Kassel KM; Schulte NA; Parker SM; Lanik AD; Toews ML
J Pharmacol Exp Ther; 2007 Oct; 323(1):109-18. PubMed ID: 17640953
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
4. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells.
Cook SJ; Beltman J; Cadwallader KA; McMahon M; McCormick F
J Biol Chem; 1997 May; 272(20):13309-19. PubMed ID: 9148952
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells.
Cook SJ; McCormick F
Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):237-45. PubMed ID: 8947493
[TBL] [Abstract][Full Text] [Related]
7. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
Gao Y; Tang S; Zhou S; Ware JA
J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627
[TBL] [Abstract][Full Text] [Related]
8. ANG II and LPA induce Pyk2 tyrosine phosphorylation in intestinal epithelial cells: role of Ca2+, PKC, and Rho kinase.
Wu SS; Chiu T; Rozengurt E
Am J Physiol Cell Physiol; 2002 Jun; 282(6):C1432-44. PubMed ID: 11997258
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.
Kue PF; Taub JS; Harrington LB; Polakiewicz RD; Ullrich A; Daaka Y
Int J Cancer; 2002 Dec; 102(6):572-9. PubMed ID: 12447997
[TBL] [Abstract][Full Text] [Related]
10. Wound-induced ATP release and EGF receptor activation in epithelial cells.
Yin J; Xu K; Zhang J; Kumar A; Yu FS
J Cell Sci; 2007 Mar; 120(Pt 5):815-25. PubMed ID: 17284517
[TBL] [Abstract][Full Text] [Related]
11. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.
Belcheva MM; Tan Y; Heaton VM; Clark AL; Coscia CJ
Mol Pharmacol; 2003 Dec; 64(6):1391-401. PubMed ID: 14645669
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
13. Non-transactivational, dual pathways for LPA-induced Erk1/2 activation in primary cultures of brown pre-adipocytes.
Holmström TE; Mattsson CL; Wang Y; Iakovleva I; Petrovic N; Nedergaard J
Exp Cell Res; 2010 Oct; 316(16):2664-75. PubMed ID: 20576526
[TBL] [Abstract][Full Text] [Related]
14. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.
Goppelt-Struebe M; Fickel S; Reiser CO
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Tveteraas IH; Aasrum M; Brusevold IJ; Ødegård J; Christoffersen T; Sandnes D
Tumour Biol; 2016 Feb; 37(2):2519-26. PubMed ID: 26386720
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor.
Shah BH; Baukal AJ; Shah FB; Catt KJ
Mol Endocrinol; 2005 Oct; 19(10):2535-48. PubMed ID: 15928312
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of epidermal growth factor receptor by hydrogen peroxide and flagellin in cultured lung alveolar epithelial cells.
Nishi H; Maeda N; Izumi S; Higa-Nakamine S; Toku S; Kakinohana M; Sugahara K; Yamamoto H
Eur J Pharmacol; 2015 Feb; 748():133-42. PubMed ID: 25542757
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.
He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y
Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
20. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
